NCT04231136

Study to Evaluate the Pharmacodynamics After Single Oral Dosing of Tegoprazan, EAPA115 and RAPA115 in Healthy Volunteers

An Open-label, Randomized, Crossover Study to Evaluate the Pharmacodynamics After Single Oral Dosing of Tegoprazan, EAPA115 and RAPA115 in Healthy Volunteers

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 19 (actual)
• Sponsor: HK inno.N Corporation · Industry
• Sex: All
• Age: 19 Years – 64 Years
• Healthy volunteers: Accepted

Summary

This study aims to evaluate the pharmacodynamics after single oral dosing of tegoprazan, EAPA115 and RAPA115 in healthy volunteers.

Detailed description

Evaluation Criteria * Pharmacodynamic assessments with intragastric pH * Safety assessments with adverse event monitoring including subjective/objective symptoms, physical examination, vital signs, electrocardiogram, and laboratory test

Conditions

• Healthy

Interventions

Type	Name	Description
DRUG	Tegoprazan 50 mg	Tegoprazan 50 mg tablet
DRUG	EAPA115	EAPA115
DRUG	RAPA115	RAPA115

Timeline

• Start date: 2020-01-14
• Primary completion: 2020-07-29
• Completion: 2020-08-03
• First posted: 2020-01-18
• Last updated: 2020-12-01

Locations

1 site across 1 country: South Korea